Sirolimus 1mg

SKU GME241
1–9 boxes $45.00 each
10–24 boxes 8% off
25+ boxes 10% off

Product Introduction

Sirolimus 1mg is an immunosuppressant used to prevent organ transplant rejection and in selected specialist conditions. It lowers immune activity to protect transplanted organs or control abnormal cell growth pathways. The information is written to support clear product identification and practical page display.

How to use

Take at the same time each day, consistently with or without food. Blood-level monitoring may be needed to keep levels in a safe range. Match the route to the product form before use.

How it works

Sirolimus blocks mTOR signalling, reducing immune-cell activation and cell growth. This helps prevent rejection in transplant therapy. The action described by the medicine class explains its main therapeutic role.

Common side effects

Common side effects include mouth ulcers, swelling, high cholesterol, acne, diarrhoea, headache, high blood pressure and increased infection risk.

Important information

Extra caution is needed with infection, liver disease, wound healing, high cholesterol and medicines that strongly affect CYP3A enzymes. Check storage instructions and expiry before use.

Shopping Cart

International B2B Enquiry

Sirolimus 1mg Export Support from India

Enquire for regulated international sourcing support for Sirolimus 1mg under General Medicines. Global Medicines Export assists eligible buyers with product information, documentation coordination, and shipment-ready enquiry support.

Category
General Medicines
Documentation
Invoice, packing list, COA/COO support where applicable

Export Enquiry Markets

USA UK New Zealand China Taiwan South Korea Argentina Brazil Mexico Australia Japan Malaysia Singapore South Africa Azerbaijan Kenya Russia Saudi Arabia Nigeria France Germany Canada Netherlands UAE Egypt Vietnam Thailand Philippines Indonesia Turkey Chile Colombia Peru Tanzania Uganda Ghana Qatar Kuwait

Prescription and regulated medicines are supplied only subject to buyer eligibility, destination-country rules, and required documentation. This content is for B2B product enquiry, not medical advice.

Catalogue signal refreshed: September 2026